Endothelin-1: An Emerging Biomarker for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction

被引：0
|
作者：
Nugroho, Dhite Bayu [1 ,2 ]
机构：
[1] Gadjah Mada Univ, Dept Internal Med, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia
[2] Gadjah Mada Univ, Fac Med Publ Hlth & Nursing, Clin Epidemiol & Biostat Unit, Yogyakarta, Indonesia
来源：
CARDIOLOGY | 2019年 / 143卷 / 3-4期
关键词：
D O I：
10.1159/000501899
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [31] Tofogliflozin Improves Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction Mice
    Joki, Yusuke
    Konishi, Hakuoh
    Takasu, Kiyoshi
    Minamino, Tohru
    CIRCULATION, 2020, 142
  • [32] Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
    Dachs, Theresa-Marie
    Duca, Franz
    Rettl, Rene
    Binder-Rodriguez, Christina
    Dalos, Daniel
    Ligios, Luciana Camuz
    Kammerlander, Andreas
    Grunig, Ekkehard
    Pretsch, Ingrid
    Steringer-Mascherbauer, Regina
    Ablasser, Klemens
    Wargenau, Manfred
    Mascherbauer, Julia
    Lang, Irene M.
    Hengstenberg, Christian
    Badr-Eslam, Roza
    Kastner, Johannes
    Bonderman, Diana
    EUROPEAN HEART JOURNAL, 2022, 43 (36) : 3402 - 3413
  • [33] Impact of the New Definition of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    Sera, Fusako
    Ohtani, Tomohito
    Nakamoto, Kei
    Hikoso, Shungo
    Nakatani, Daisaku
    Tamaki, Shunsuke
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Yasumura, Yoshio
    Yamada, Takahisa
    Yamauchi-Takihara, Keiko
    Sakata, Yasushi
    CIRCULATION, 2020, 142
  • [34] Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction
    Agarwal, Richa
    Shah, Sanjiv J.
    Foreman, Aimee J.
    Glassner, Cherylanne
    Bartolome, Sonja D.
    Safdar, Zeenat
    Coslet, Sandra L.
    Anderson, Allen S.
    Gomberg-Maitland, Mardi
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (05): : 467 - 477
  • [35] Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
    Thenappan, Thenappan
    Shah, Sanjiv J.
    Gomberg-Maitland, Mardi
    Collander, Brett
    Vallakati, Ajay
    Shroff, Pranavkumar
    Rich, Stuart
    CIRCULATION-HEART FAILURE, 2011, 4 (03) : 257 - U71
  • [36] Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
    Ovchinnikov, Artem
    Potekhina, Alexandra
    Belyavskiy, Evgeny
    Ageev, Fail
    PHARMACEUTICALS, 2022, 15 (08)
  • [37] Pulmonary arterial hypertension and heart failure with preserved ejection fraction: are they so discordant?
    Ruocco, Gaetano
    Gavazzi, Antonello
    Gonnelli, Stefano
    Palazzuoli, Alberto
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (03) : 534 - 545
  • [38] New Definition of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction
    Nishihara, Taiki
    Yamamoto, Eiichiro
    Tokitsu, Takanori
    Sueta, Daisuke
    Fujisue, Koichiro
    Usuku, Hiroki
    Takashio, Seiji
    Sakamoto, Kenji
    Kaikita, Koichi
    Tsujita, Kenichi
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (03) : 386 - 388
  • [39] Pathobiological characterization of pulmonary hypertension associated with heart failure with preserved ejection fraction
    Zimmermann, L.
    Mueller, R.
    Gnatzy-Feik, L.
    Berghausen, E.
    Zierden, M.
    Vantler, M.
    Baldus, S.
    Rosenkranz, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction
    Fares, Wassim H.
    Kaminski, Naftali
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (04) : 421 - 422
12345